CHU Strasbourg Hôpital de Hautepierre

Strasbourg 67098

0 studies enrolling now · 4 studies all time

What they study most

Alzheimer's Disease, Lupus Erythematosus, Systemic, Magnetic Resonance Imaging, Scleroderma, Systemic

Studies at this site

• Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose — Completed
• Efficacy and Safety of Riociguat in Patients With Systemic Sclerosis — Completed
• A Study of Lanabecestat (LY3314814) in Participants With Mild Alzheimer's Disease Dementia — Stopped early
• A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus — Completed